YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA INTERLEYKIN-6 AHAMIYATI

ORIGINAL SOURCE
Originally published in "Conference on Universal Science Research 2023"; Vol. 2 No. 5 (2024): Conference on Universal Science Research 2023; 92-95.
View & download PDFOpen original source

G`opirjonova, D.D and Alyavi, A.L (2024) YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA INTERLEYKIN-6 AHAMIYATI. "Conference on Universal Science Research 2023"; Vol. 2 No. 5 (2024): Conference on Universal Science Research 2023; 92-95.

[thumbnail of 11368.pdf] PDF
11368.pdf - Published Version
Download (467kB)

Abstract

Yallig`lanish bu yurak ishemik kasalligida (YuIK) ishtirok etuvchi muhim jarayon hisoblanadi. Metabolik stress, gemodinamik ortiqcha yuk va endoteliy va miyokard hujayralarida neyrogumaral giperaktivatsiyaga javoban interleykin (IL) 1 va 6 kabi yallig`lanishga qarshi sitokinlar chiqariladi. Dastlab, bu jarayon organizimni stresga moslashishini taminlaydi, ammo keyinchlik kasallik davrida ular endothelial va yurak disfunktsiyasi orqali miyokard fibroziga olib keladigan zararli ta`sirlarni keltirib chiqaradi. Tadqiqotlar shuni ko`rsatadiki yurak ishemik kasalligida bemorlarda interleykin(IL)6 yallig`lanish mediatori ko`payib ketadi.

Item Type: Article
Additional Information: Imported from Conference on Universal Science Research 2023
SWORD Depositor: Admin User
Depositing User: Admin User
Date Deposited: 28 Sep 2026 22:14
Last Modified: 28 Sep 2026 22:14
URI: https://universalpublishings.uz/id/eprint/15328

Actions (login required)

View Item
View Item